Innovent and Incyte Enter Strategic Collaboration and Licensing Agreement

Delaware Bids | News

Dec 26, 2018

The agreement is for three clinical-stage product candidates discovered and developed by Incyte-pemigatinib (FGFR1/2/3 inhibitor), itacitinib (JAK1 inhibitor) and parsaclisib (PI3K…